Clinical Implications of Hepatocyte Growth Factor, Interleukin-20, and Interleukin-22 in Serum and Bronchoalveolar Fluid of Patients with Non-Small Cell Lung Cancer.

Autor: Naumnik, W., Naumnik, B., Niklińska, W., Ossolińska, M., Chyczewska, E.
Zdroj: Advancements in Clinical Research; 2016, p41-49, 9p
Databáze: Complementary Index